Klassen P, Schiessel DL, Baracos VE. Adverse effects of systemic cancer therapy on skeletal muscle: myotoxicity comes out of the closet. Curr Opin Clin Nutr Metab Care 2023. [PMID: 36942895 DOI: 10.1097/MCO.0000000000000922][Reference Citation Analysis]
2
Yalçın T, Kaya S. Thymoquinone may alleviate cisplatin-induced muscle atrophy in rats by regulating mitofusin 2 and meteorin-like levels. Comp Clin Pathol 2023. [DOI: 10.1007/s00580-023-03442-9][Reference Citation Analysis]
Sakai H, Suzuki Y, Miyauchi Y, Sato F, Ando Y, Kon R, Ikarashi N, Chiba Y, Kamei J, Hosoe T. Downregulation of Sparc-like protein 1 during cisplatin-induced inhibition of myogenic differentiation of C2C12 myoblasts. Biochem Pharmacol 2022;:115234. [PMID: 36041542 DOI: 10.1016/j.bcp.2022.115234][Reference Citation Analysis]